Post-earnings recap
Reported
Tue, Jul 27, 2021
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
50%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Teladoc Health's earnings report reflects significant challenges, particularly with EPS missing expectations. Despite this, the stock rose slightly by 0.84%, indicating that investors may be optimistic about the company's long-term potential despite current hurdles. The lack of revenue data and guidance adds uncertainty moving forward.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.86 | N/A | -46.51% |
| Revenue | N/A | N/A | N/A |
Management acknowledged the difficulties faced during the quarter. They remain committed to their strategic initiatives but did not provide specific guidance.
Management highlighted ongoing challenges in the market.
They emphasized a focus on long-term growth despite short-term setbacks.